We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01656616
Recruitment Status : Withdrawn
First Posted : August 3, 2012
Last Update Posted : May 18, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.

Condition or disease Intervention/treatment
Cyanide Poisoning Drug: Cyanide antidote administration

Study Design

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis
Actual Study Start Date : August 1, 2012
Primary Completion Date : August 1, 2012
Study Completion Date : August 1, 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
EMS cyanide exposure patients Drug: Cyanide antidote administration


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
EMS patients possibly exposed to cyanide via poisoning or smoke exposure.
Criteria

Inclusion Criteria:

  • Included in Maine EMS database
  • House Fire Victim
  • Poisoning

Exclusion Criteria:

  • No potential cyanide exposure
  • Incomplete data available
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01656616


Locations
United States, Maine
Maine Medical Center Department of Emergency Medicine
Portland, Maine, United States, 04102
Sponsors and Collaborators
Maine Medical Center
Investigators
Study Director: Tania D Strout, PhD, RN, MS Maine Medical Center
More Information

Responsible Party: Katrina G. Ferguson, Director of Research, Department of Emergency Medicine, Maine Medical Center
ClinicalTrials.gov Identifier: NCT01656616     History of Changes
Other Study ID Numbers: IRB 4053X
First Posted: August 3, 2012    Key Record Dates
Last Update Posted: May 18, 2017
Last Verified: May 2017

Keywords provided by Katrina G. Ferguson, Maine Medical Center:
Pharmacoeconomics
Cost effectiveness
Cyanide
Fire
Emergency Medical Services
Smoke Inhalation

Additional relevant MeSH terms:
Emergencies
Poisoning
Disease Attributes
Pathologic Processes
Chemically-Induced Disorders
Antidotes
Hydroxocobalamin
Vitamin B 12
Protective Agents
Physiological Effects of Drugs
Hematinics
Vitamin B Complex
Vitamins
Micronutrients
Growth Substances